CD9 antigen peptides and antibodies thereto
OwnerGary S. Grayinventor
Life of this patent
Estimating the term…
Abstract
Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the accessory molecule are described. T cell proliferation occurs in the absence of exogenous growth factors or accessory cells. T cell activation is accomplished by stimulating the T cell receptor (TCR)/CD3 complex or the CD2 surface protein. To induce proliferation of an activated population T cells, an accessory molecule on the surface of the T cells, such as CD28, is stimulated with a ligand which binds the accessory molecule. The T cell population expanded by the method of the invention can be genetically transduced and used for immunotherapy or can be used in methods of diagnosis.
Claims6
An isolated peptide having an amino acid sequence (Xaa.sub.1).sub.n -Gly-Xaa.sub.2 -Trp-Leu-Xaa.sub.3 -Xaa.sub.4 -Asp(Glu)-(Xaa.sub.5).sub.n (SEQ ID NO:
- 5), wherein Xaa.sub.4 may or may not be present, Xaa.sub.1, Xaa.sub.2, Xaa.sub.3, Xaa.sub.4 and Xaa.sub.5 are any amino acid residue and n=0-20.
A monoclonal antibody which specifically binds to a CD9 antigen present on activated T cells, thereby stimulating or enhancing T cell proliferation, wherein the monoclonal antibody specifically binds a peptide having an amino acid sequence (Xaa.sub.1).sub.n -Gly-Xaa.sub.2 -Trp-Leu-Xaa.sub.3 -Xaa.sub.4 -Asp(Glu)-(Xaa.sub.5).sub.n (SEQ ID NO:
- 5), wherein Xaa.sub.4 may or may not be present, Xaa.sub.1, Xaa.sub.2, Xaa.sub.3, Xaa.sub.4 and Xaa.sub.5 are any amino acid residue and n=0-20.
Dependencies are inferred from the claim text.